MNKDDoubtfulB
Unlock full report, free
MannKind Corporation

MNKD: Is MannKind Corporation Halal?

MannKind Corporation

NASDAQHealthcareUS

$4.07

Price as of Aug 25, 2026

Market Cap: 1.3B

Screened on a market cap of 1.1B

Compliance Status

Doubtful

Screened on Sep 15, 2026 · AAOIFI Standard 21

B

Acceptable

64Score

Is MannKind Corporation (MNKD) halal? Doubtful. Based on AAOIFI screening, MannKind Corporation passes the business activity screen but has financial ratios approaching AAOIFI limits with a compliance score of 64/100 (Grade: B).

Quote this verdict

HalalScreener rates MannKind Corporation (MNKD) Doubtful, 64/100, grade B under AAOIFI Standard 21, screened Sep 15, 2026. Source: https://halalscreener.app/en/stock/MNKD

Business activity

What the company sells is permissible.

Passed

Company debt

Close to the limit

How much the company borrows, compared to its total value. AAOIFI allows up to 30%.

28.1% of 30.0% limit
PRO DETAIL

The verdict above is final and free.

Pro members can verify every number behind it: interest-bearing deposits, prohibited income breakdown, and the full AAOIFI math.

Screened according to AAOIFI Standard 21

What this means for you

You may own MNKD, with caution

Its numbers sit close to AAOIFI limits. Cautious investors may prefer alternatives or ask a scholar first.

Purification amount is Pro

We have screened MNKD's prohibited income, but the exact share you would need to purify is part of Pro.

Get an email if MNKD's halal status changes

We re-screen MannKind Corporation daily. If the verdict moves, you hear about it the same day.

Free. One click sets it up, and you can unsubscribe any time.

About MannKind Corporation

MannKind Corporation operates as a biopharmaceutical firm, primarily focused on innovating and bringing to market respiratory-delivered treatments. Its efforts are directed towards tackling endocrine system disorders and rare lung conditions within the U.S. market. The company's key product is Afrezza, an inhaled insulin designed to improve glycemic control for adults managing diabetes. MannKind also actively markets Thyquidity, promoting it to adult and pediatric endocrinologists and other healthcare professionals for the treatment of hypothyroidism. In terms of collaborations, MannKind holds a strategic licensing and partnership agreement with United Therapeutics Corporation. Furthermore, it is collaborating with NRx Pharmaceuticals to develop a dry powder formulation of ZYESAMI (aviptadil), which is a synthetic variant of human vasoactive intestinal peptide intended to shield cells from inflammatory processes. Established in 1991, MannKind Corporation's corporate offices are located in Westlake Village, California.

Sector: Healthcare · Industry: Biotechnology

Why This Stock Is Doubtful

  • Interest-bearing debt is 28.1% of market cap, only 1.9 points below the 30% AAOIFI limit.

Stocks are marked Doubtful when financial ratios pass but approach AAOIFI thresholds. Consider consulting a qualified scholar for a definitive ruling.

Shariah Compliance Status

AAOIFI Standard 21Updated Sep 15, 2026

See which ratio caused the failure.

See the exact debt ratio, interest income %, and prohibited revenue that caused the failure. Know before you sell or hold.

Free for 7 days. Cancel anytime.

AI Compliance Insight

PRO

Institutional-grade Shariah analysis

See why MNKD is rated Doubtful with institutional-grade analysis

PRO DETAIL

The verdict above is final and free.

Pro members can verify every number behind it: interest-bearing deposits, prohibited income breakdown, and the full AAOIFI math.

Screened according to AAOIFI Standard 21

Compliance History

  1. Doubtfulnow

    since Sep 2026

  2. Halal

    until the change above

  3. Doubtful

    until the change above

  4. Halal

    until the change above

  5. Doubtful

    until the change above

  6. Halal

    until the change above

  7. Doubtful

    until the change above

  8. Not Halal

    until the change above

Tracked since Jun 2026. Updates automatically on each re-screen.

Fiscal: Q2 2026Data source: EDGAR
Free · No credit card required

Track MNKD and 8,200+ stocks with AI insights

Create your free account to unlock AI-powered compliance analysis, track your portfolio, calculate purification, and get unlimited AAOIFI screening.

8,200+ assets AAOIFI standards Free watchlist

Frequently Asked Questions

Is MannKind Corporation (MNKD) halal to invest in?
MannKind Corporation (MNKD) is rated Doubtful under AAOIFI Standard 21. It passes the business activity screen but one or more financial ratios are approaching (though not yet exceeding) the AAOIFI thresholds (30% for debt and interest deposits, 5% for prohibited income). Consult a qualified Islamic finance scholar for a personal ruling.
Why did MannKind Corporation get a B compliance rating?
MannKind Corporation (MNKD) received a grade of B (Acceptable) based on three AAOIFI Standard 21 financial ratios: debt-to-market-cap of 28.1% (limit 30%). The grade reflects the margin of safety across all three ratios relative to their thresholds.
What could change MannKind Corporation's Shariah verdict?
MannKind Corporation's verdict is re-evaluated at each annual re-screen. Three events could change it: (1) the debt-to-market-cap ratio crossing 30%, typically from new debt issuance or a major drop in share price; (2) interest-bearing deposits exceeding 30% of market cap; or (3) prohibited revenue (alcohol, gambling, conventional finance, etc.) exceeding 5% of total revenue. Verdict flips are tracked in the compliance history section above.
How often is MannKind Corporation re-screened for Shariah compliance?
MannKind Corporation (MNKD) is re-screened annually using the most recent full-year financial data from SEC filings. HalalScreener also triggers an on-demand re-screen whenever the stored data is more than 7 days old, ensuring the ratios reflect the latest available financial statements. Last screened: Sep 15, 2026.

Screened according to AAOIFI Standard No. 21 · For informational purposes only. Consult a qualified Islamic finance advisor before investing.

Disclaimer: This screening is for informational purposes only and does not constitute financial, legal, or religious advice. Compliance is evaluated using AAOIFI financial standards (debt, deposits, and prohibited income ratios) and publicly available data. Ethical, political, social, or environmental considerations are outside the scope of this screening. Individual scholars and methodologies may differ. Always consult a qualified Islamic finance advisor before making investment decisions.